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Abstract
Although cell lysis by the hemolytic peptide, melittin, has been extensively studied, the role of specific lipids of the erythrocyte
membrane on melittin-induced hemolysis remains unexplored. In this report, we have explored the modulatory role of cholesterol
on the hemolytic activity of melittin by specifically depleting cholesterol from rat erythrocytes using methyl--cyclodextrin
(MCD). Our results show that the hemolytic activity of melittin is increased by∼3-fold upon depletion of erythrocyte membrane
cholesterol by∼55% without any appreciable loss of phospholipids. This result constitutes the first report demonstrating that the
presence of cholesterol inhibits the lytic activity of melittin in its natural target membrane, i.e., the erythrocyte membrane. These
results are relevant in understanding the role of cholesterol in the mechanism of action of melittin in the erythrocyte membrane.
© 2005 Elsevier Ireland Ltd. All rights reserved.
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0. Introduction
Melittin is the principal toxic component in the
enom of the European honey bee, Apis mellif-
ra. It is a small linear peptide composed of 26
mino acid residues (NH2-GIGAVLKVLTTGLPALI-
WIKRKRQQ-CONH2) and is known to have pow-
rful hemolytic activity (Habermann, 1972; Tosteson
t al., 1985; Dempsey, 1990). It is a cationic peptide in
hich the amino-terminal is composed predominantly
f hydrophobic amino acids (residues 1–20), whereas
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the carboxy-terminal end has a stretch of predom-
inantly hydrophilic amino acids (residues 21–26),
which give rise to its amphiphilic character. This am-
phiphilic property of melittin makes it water-soluble,
and yet it spontaneously associates with natural and ar-
tificial membranes (Dempsey, 1990). Such a sequence
of amino acids, coupled with its amphiphilic nature, is
characteristic of many membrane-bound peptides and
putative transmembrane helices of membrane proteins
(Dempsey, 1990). This has resulted in melittin being
used as a convenient model to monitor lipid–protein
interactions in membranes and membrane-mimetic
systems (Hristova et al., 2001; Raghuraman
and Chattopadhyay, 2003; Raghuraman and
Chattopadhyay, 2004).
009-3084/$ – see front matter © 2005 Elsevier Ireland Ltd. All rights reserved.
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Despite the availability of a high-resolution (2 A˚)
crystal structure of tetrameric melittin in aqueous so-
lution (Terwilliger and Eisenberg, 1982), the structure
of the membrane-bound form is not yet resolved by
X-ray crystallography. Since the association of the
peptide in the membrane is linked to its physiological
effects (Dempsey, 1990), understanding the interac-
tion of melittin with membrane components assumes
significance. The importance of the membrane-bound
form also stems from the observation that the am-
phiphilic -helical conformation of this hemolytic
toxin in membranes resembles those of signal peptides
(Golding and O’Shea, 1995), and the envelope glyco-
protein gp41 from the human immunodeficiency virus
(HIV) (Rabenstein and Shin, 1995). Furthermore, un-
derstanding melittin–membrane interaction assumes
greater significance due to the recent finding that
melittin mimics the N-terminal of HIV-1 virulence
factor Nef1-25 (Barnham et al., 1997).
Cholesterol is an essential component of eukary-
otic membranes and plays a crucial role in membrane
organization, dynamics, function and sorting (Yeagle,
1985; Simons and Ikonen, 2000). It is often found dis-
tributed non-randomly in domains or pools in biologi-
cal and model membranes (Simons and Ikonen, 2000;
Simons and Ikonen, 1997; Rukmini et al., 2001). Many
of these domains are believed to be important for the
maintenance of membrane structure and function. Re-
cent observations suggest that cholesterol exerts many
of its actions by maintaining a specialized type of mem-
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anism (Tosteson et al., 1985). However, the role of
membrane lipids of the erythrocyte membrane on the
melittin-induced hemolysis is not clear. Studies us-
ing model membranes have shown that the presence
of cholesterol in the membrane inhibits the lytic ac-
tivity of melittin (Benachir et al., 1997; Raghuraman
and Chattopadhyay, 2004). We have recently shown
that melittin could interact preferentially with
cholesterol in model membranes (Raghuraman and
Chattopadhyay, 2004). However, the effect of choles-
terol on the lytic activity of melittin in erythrocyte
membranes is not yet known. In this paper, we have
explored the modulatory role of cholesterol on the
hemolytic activity of melittin by specifically deplet-
ing cholesterol from rat erythrocytes using methyl-
-cyclodextrin (MCD), which selectively and effi-
ciently extracts cholesterol from membranes by includ-
ing it in a central nonpolar cavity (Christian et al., 1997;
Steck et al., 2002). Our results show that depletion of
cholesterol by ∼55% without any appreciable loss of
phospholipids increases the hemolytic activity of melit-
tin by ∼3-fold. This novel result constitutes the first
report demonstrating that the presence of cholesterol
inhibits the lytic activity of melittin in its natural target
membrane, i.e., the erythrocyte membrane.
2. Experimental procedures
2.1. Materials
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urane domain termed “lipid raft” in a functional state
Simons and Ikonen, 1997), although the existence of
ipid rafts in membranes has not been unequivocally
hown (Munro, 2003). In view of the importance of
holesterol in relation to membrane domains, the inter-
ction of cholesterol with membrane proteins (Yeagle,
985; Burger et al., 2000) represents an important de-
erminant in functional studies of such proteins.
The most characteristic effect of melittin on cell
embranes is its lytic activity (Habermann, 1972;
osteson et al., 1985; Dempsey, 1990). The nat-
ral target for melittin is the erythrocyte mem-
rane, which contains high amounts (∼45 mol%)
f cholesterol (Yeagle, 1985). It has been shown
hat melittin binds rapidly to erythrocytes and in-
uces the release of hemoglobin (Tosteson et al.,
985; Dempsey, 1990). Melittin-induced hemolysis
as been reported to occur by a colloid-osmotic mech-Melittin, DMPC (1,2-dimyristoyl-sn-glycero-3-
hosphocholine), and HEPES were obtained from
igma Chemical Co. (St. Louis, MO, USA). To
heck for any residual phospholipase A2 contamina-
ion in melittin, phospholipase activity was assayed
sing 14C-labeled DOPC (1,2-dioleoyl-sn-glycero-3-
hosphocholine) (Amersham International, Bucking-
amshire, UK) as described earlier (Ghosh et al., 1997).
he concentration of melittin in aqueous solution was
alculated from its molar extinction coefficient (ε) of
570 M−1 cm−1 at 280 nm (Ghosh et al., 1997). Am-
lex Red cholesterol assay kit was from Molecular
robes (Eugene, OR, USA). All other chemicals used
ere of the highest purity available. Solvents used were
f spectroscopic grade. Water was purified through a
illipore (Bedford, MA, USA) Milli-Q system and
sed throughout.
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2.2. Methods
2.2.1. Assay for hemolytic activity
The hemolytic activity of melittin was evaluated
using Wistar rat erythrocytes as described previously
(Subbalakshmi et al., 1999). Erythrocytes were isolated
from heparinized blood by centrifugation at 3000 rpm
for 5 min and washed three times with HEPES buffer
(5 mM HEPES, 150 mM NaCl, pH 7.4). An aliquot of
washed erythrocytes was kept separately for carrying
out cholesterol depletion. Increasing concentrations of
melittin were added to aliquots of 0.5 ml suspension,
which correspond to ∼107 cells in Eppendorf tubes
and were incubated at 37 ◦C in duplicates for 30 min
with gentle mixing. The tubes were then centrifuged
and the absorbance of the released hemoglobin in the
supernatants was measured at 540 nm in a 96-well mi-
crotitre plate. The hemolysis obtained with water was
taken as 100%. The cell suspension in buffer in the
absence of melittin served as background control. The
hemolytic activity of melittin in cholesterol-depleted
erythrocyte membranes was evaluated the same way.
All hemolytic assays were carried out on the same day
of blood collection.
2.2.2. Cholesterol depletion of rat erythrocyte
membranes
Rat erythrocyte membranes were depleted of
cholesterol using MCD as described earlier (Samuel
et al., 2001). Briefly, 2× 109 intact erythrocytes,
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estimation of total phospholipids obtained from the cell
lysates after spinning them down and from lipid ex-
tracts yielded similar values, thereby ensuring that the
extraction process was efficient and complete.
2.2.4. Estimation of inorganic phosphate
Concentration of lipid phosphate of lipid extracts
from control and cholesterol-depleted erythrocytes was
determined subsequent to total digestion by perchlo-
ric acid (McClare, 1971) using Na2HPO4 as standard.
DMPC was used as an internal standard to assess com-
plete lipid digestion. Samples without perchloric acid
digestion produced negligible readings.
3. Results
Extraction of lipids from control and cholesterol-
depleted erythrocytes was carried out using widely
used extraction procedures (Kates, 1986; Rose and
Oklander, 1965), which ensures quantitative extrac-
tion. Cholesterol depletion by the water-soluble com-
pound MCD has earlier been shown to be dependent
on the concentration of MCD used, time of incu-
bation, and cell type. Importantly, MCD has previ-
ously been shown to selectively and efficiently extract
cholesterol from erythrocyte membranes (Steck et al.,
2002; Samuel et al., 2001; Rivas and Gennaro, 2003).
However, it has recently been reported that cholesterol
depletion using MCD can lead to depletion of other
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tashed free of serum, were resuspended in HEPES
uffer containing 5 mM MCD and incubated for
0 min at 37 ◦C with mild shaking, following which
xcess MCD was washed off twice and resuspended
n HEPES buffer.
.2.3. Extraction of lipids from rat erythrocytes
Lipids were extracted from RBC using both
ligh–Dyer (Kates, 1986) and Rose–Oklander method
Rose and Oklander, 1965). All extractions were pre-
eded by complete lysis of the packed erythrocytes with
n equal volume of distilled water. Total phospholipid
ontent of both control and cholesterol-depleted ery-
hrocyte membranes was determined after lipid extrac-
ion as described below and cholesterol content was
etermined using the Amplex Red cholesterol assay kit
Amundson and Zhou, 1999). Lipid extracts obtained
sing both methods yielded similar results. In addition,lasses of lipids under certain conditions (Ottico et al.,
003). It is, therefore, necessary to show that depletion
f cholesterol is specific and does not lead to deple-
ion of phospholipids under the conditions used. To
nsure this, we estimated phospholipid and cholesterol
ontents upon MCD treatment of erythrocytes. The
ffect of 5 mM MCD treatment on the lipid compo-
ition of rat erythrocytes is shown in Fig. 1. The figure
hows that the cholesterol content of MCD-treated
rythrocytes is reduced by∼55% of the value of control
rythrocytes. It is reassuring to note that the change in
hospholipid content under identical conditions is neg-
igible (∼2%). This shows that the depletion of choles-
erol by MCD is specific.
The change in cholesterol-to-phospholipid (C/PL)
atio (mol/mol) upon cholesterol depletion in erythro-
ytes is shown in Table 1. The table shows that con-
rol erythrocytes have C/PL ratio of 0.73, whereas
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Fig. 1. Effect of 5 mM MCD treatment (shaded bars) on lipid
composition of rat erythrocytes. Values are expressed as percent-
ages of the respective lipid content in control erythrocytes with-
out MCD treatment (white bars). Phospholipid and cholesterol
contents were assayed as described in Section 2. Data shown are
the means±S.E. of at least three independent measurements. The
cholesterol-to-phospholipid ratio (mol/mol) for both control and
cholesterol-depleted erythrocytes is shown in Table 1.
cholesterol-depleted erythrocytes have C/PL ratio of
0.32. This implies presence of ∼42 and ∼24 mol%
cholesterol in control and cholesterol-depleted ery-
throcytes, respectively, with respect to their total lipid
(phospholipid plus cholesterol) contents. The concen-
tration of MCD used in this study, therefore, helps
in selectively depleting a significant amount of choles-
terol without affecting the phospholipid content (see
Fig. 1).
Fig. 2 shows the extent of hemolysis in control and
cholesterol-depleted erythrocytes as a function of in-
creasing concentration of melittin. As shown in the
figure, increasing concentration of melittin drastically
increases the release of hemoglobin, which is indica-
Table 1
Change in cholesterol-to-phospholipid ratio (C/PL) in erythrocytes
upon cholesterol depletiona
Erythrocytes C/PL ratiob (mol/mol)
Control 0.73± 0.03
Cholesterol-depleted 0.32± 0.01
a The amount of cholesterol depleted using 5 mM MCD was 55%
(see Fig. 1). See Section 2 for other details.
b Control erythrocytes have ∼42 mol% cholesterol whereas
cholesterol-depleted erythrocytes have ∼24% cholesterol with re-
spect to their phospholipid content. Phospholipid and cholesterol
contents were determined after lipid extraction. The values shown
are the means±S.E. of at least three independent measurements.
See Section 2 for other details.
Fig. 2. Hemolysis of untreated (©) and MCD-treated () rat
erythrocytes as a function of increasing concentration of melittin.
The hemolytic assay was carried out at room temperature (23 ◦C).
The data points shown are the means±S.E. of at least three in-
dependent measurements. See Section 2 and Table 2 for other
details.
tive of cell lysis. The LD50 values (the concentration
required for 50% lysis) for melittin-induced hemolysis
in both cases are given in Table 2. The LD50 value
for melittin-induced lysis in control erythrocytes is
found to be 0.67M in overall agreement with previ-
ously reported values (Tosteson et al., 1985; Mousli et
al., 1990). Interestingly, the LD50 value for melittin-
induced lysis in cholesterol-depleted erythrocytes is
found to be 0.21M (see Table 2). This clearly shows
that the lytic ability of melittin is more pronounced
in erythrocytes with reduced cholesterol content. In
other words, cholesterol inhibits the hemolytic activity
of melittin since the concentration of melittin required
for 50% lysis is∼3 times lower in cholesterol-depleted
erythrocytes than what is required in case of control
erythrocytes.
Table 2
Effect of cholesterol depletion on the lytic activity of melittin in
erythrocytesa
Erythrocytes LD50 (M)b
Control 0.67± 0.03
Cholesterol-depleted 0.21± 0.02
a The hemolytic activity of melittin was evaluated with ∼107 rat
erythrocytes. The amount of cholesterol depleted using 5 mM MCD
was 55%. See Section 2 for other details.
b The values shown are the means±S.E. of at least three indepen-
dent measurements. See Section 2 for other details.
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4. Discussion
Although cell lysis by melittin has been ex-
tensively studied, the molecular mechanism of
its hemolytic activity is still not well under-
stood. In particular, the role of specific lipids
on melittin-induced hemolysis is not yet clear.
In this paper, we monitored the modulatory role
of cholesterol on the hemolytic activity of melit-
tin by depleting cholesterol using MCD, a well-
characterized cholesterol-depleting agent (Pucadyil
and Chattopadhyay, 2004). Our results show that the
hemolytic ability of melittin is enhanced upon choles-
terol depletion. This could be due to increased pene-
tration of melittin caused by a change in membrane
packing in cholesterol-depleted erythrocytes since the
presence of cholesterol is known to induce tight hy-
drocarbon chain packing in membranes (Yeagle, 1985;
Mitchell and Litman, 1998). This is supported by
our recent observation that the membrane penetration
of melittin is decreased with increasing amounts of
cholesterol in model membranes (Raghuraman and
Chattopadhyay, 2004). This is further reinforced by
previous results in which it was shown that bacterial
lipopolysaccharides act similarly as cholesterol in pro-
viding protection to melittin-induced lysis due to tight
packing of the lipid acyl chains in membranes (Allende
and McIntosh, 2003). Depletion of membrane choles-
terol has previously been shown to increase the pore-
membranes is believed to be independent of any
receptors (Tosteson et al., 1985; Dempsey, 1990;
Mousli et al., 1990). Therefore, localization of any pos-
sible receptor in cholesterol-rich membrane domains,
and hence, the dependence of melittin entry on mem-
brane cholesterol does not arise. More importantly, it
has been previously shown, by analysis of binding of
melittin to membranes having characteristic lipid com-
positions resembling raft-like (detergent resistant) and
nonraft-like (detergent soluble) domains, that melittin
selectively binds to nonraft membranes (Gandhavadi et
al., 2002). The role of bilayer structure and elastic prop-
erties of membranes in peptide localization has recently
attracted a lot of attention (Chen et al., 2003; Allende et
al., 2005). The mode of action of melittin could, there-
fore, be attributed to membrane destabilization caused
by cholesterol depletion since it has been shown that
cholesterol depletion causes increased acyl chain dis-
order in erythrocyte membranes (Cassera et al., 2002).
This would favor the insertion and pore formation of
melittin.
In summary, our results show that depletion of
cholesterol increases the hemolytic activity of melit-
tin. This novel result demonstrates that the presence
of cholesterol inhibits the lytic activity of melittin
in its natural target membrane, i.e., the erythrocyte
membrane. Overall, our results are relevant in un-
derstanding the role of cholesterol in the mechanism
of action of melittin in the erythrocyte membrane
in particular, and other cytolytic peptides in general.
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Future studies in our laboratory will focus on the
etailed characterization of cholesterol-depleted ery-
hrocytes with reference to the hemolytic action of
elittin.
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ellowship.forming activity of the antifungal agent syringomycin
E in erythrocytes (Blasko et al., 1998). To the best of
our knowledge, this is the first report demonstrating the
inhibition of lytic activity of melittin in erythrocytes by
cholesterol.
The existence of membrane domains in human ery-
throcytes has previously been reported (Rodgers and
Glaser, 1991; Samuel et al., 2001). While the ex-
act nature of these domains is not still resolved,
high amounts of cholesterol in the erythrocyte mem-
brane have been shown to induce raft-like detergent-
resistant membrane microdomains (Samuel et al.,
2001). These microdomains have been reported to
act as concentration platforms to facilitate entry
of pore-forming toxins (Abrami and van der Goot,
1999). This raises the obvious question: does melittin-
induced hemolysis involve raft-like membrane do-
mains? We believe this not to be the case for
the following reasons. The action of melittin in
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